Table 2.
Pre-existing conditions and patient findings.
| Hyperoxemia (n = 25) | Normoxemia (n = 20) | p-Value | |
|---|---|---|---|
| Age | 68.36 ± 9.77 years | 67.07 ± 8.55 years | 0.64 |
| EuroSCORE II | 3.56 (3.225) | 5 (3.65) | 0.95 |
| BMI | 30.01 ± 5.77 kg/m2 | 27.93 ± 7.06 kg/m2 | 0.12 |
| Arterial hypertension | 20 (80%) | 14 (70%) | 0.66 |
| TIA | 2 (8%) | 0 (0%) | 0.57 |
| Stroke | 3 (12%) | 2 (10%) | 1.00 |
| Atrial fibrillation | 10 (40%) | 3 (15%) | 0.10 |
| Diabetes mellitus | 6 (24%) | 7 (35%) | 0.51 |
| Peripheral arterial disease | 7 (28%) | 1 (5%) | 0.10 |
| COPD | 3 (12%) | 1 (5%) | 0.76 |
| Hyperlipidemia | 10 (40%) | 6 (30%) | 0.91 |
| Condition after myocardial infarction | 9 (36%) | 3 (15%) | 0.21 |
BMI = body-mass Index; TIA= transient ischemic attack; COPD = chronic obstructive lung disease. EuroSCORE II presented median and interquartile range, and the rest presented as mean +/− SD or absolute (relative) frequencies.